Sigyn Therapeutics (SIGY) Amortizatization of Intangibles (2016 - 2023)
Sigyn Therapeutics (SIGY) posted Amortizatization of Intangibles of $300.0 for Q3 2023, down 66.67% sequentially from $900.0 in Q2 2023, and down 66.67% YoY from $900.0 in Q3 2022.
Sigyn Therapeutics (SIGY) Amortizatization of Intangibles (2016 - 2023) Analysis & Trends
Sigyn Therapeutics has reported Amortizatization of Intangibles for 8 years, with the latest figure at $300.0 in Q3 2023.
- Quarterly Amortizatization of Intangibles fell 66.67% year-over-year to $300.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $2100.0 (down 41.67% YoY) and the FY2023 annual result came in at $2100.0, down 41.67% from the prior year.
- Amortizatization of Intangibles declined to $300.0 in Q3 2023 per SIGY's latest filing, from $900.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $16297.0 in Q1 2019 and troughed at -$18309.0 in Q3 2020.
- A 5-year average of $5040.3 and a median of $900.0 in 2021 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2020 and 2021: Amortizatization of Intangibles plunged 212.35% in 2020, then jumped 104.91% in 2021.
- Over 5 years, Amortizatization of Intangibles stood at $14016.0 in 2019, then declined by 26.13% to $10354.0 in 2020, then sank by 91.31% to $900.0 in 2021, then changed by 0.0% to $900.0 in 2022, then slumped by 66.67% to $300.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $300.0, $900.0, and $900.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 300.00 |
| Sep 30, 2023 | 300.00 |
| Jun 30, 2023 | 900.00 |
| Jun 30, 2023 | 900.00 |
| Mar 31, 2023 | 900.00 |
| Mar 31, 2023 | 900.00 |
| Dec 31, 2022 | 900.00 |
| Dec 31, 2022 | 900.00 |
| Sep 30, 2022 | 900.00 |
| Sep 30, 2022 | 900.00 |
| Jun 30, 2022 | 900.00 |
| Jun 30, 2022 | 900.00 |
| Mar 31, 2022 | 900.00 |
| Mar 31, 2022 | 900.00 |
| Dec 31, 2021 | 900.00 |
| Dec 31, 2021 | 900.00 |
| Sep 30, 2021 | 899.00 |
| Sep 30, 2021 | 899.00 |
| Jun 30, 2021 | 4,052.00 |
| Jun 30, 2021 | 4,052.00 |